Related Experiment Video
Updated: Apr 18, 2026

Novel Diagnostics in Revision Arthroplasty: Implant Sonication and Multiplex Polymerase Chain Reaction
Published on: December 3, 2017
An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the
Dolors Rodríguez-Pardo1, Carles Pigrau, Pablo S Corona
1Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Insights
Early periprosthetic joint infection (PJI) management often involves debridement, antibiotics, and implant retention. However, optimal antibiotic selection and duration for these early PJI cases require further research and evidence.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Pharmacology
Background:
- Periprosthetic joint infection (PJI) is a severe complication after arthroplasty.
- Early PJI, occurring within the first year, can often be treated with debridement, antibiotics, and implant retention (DAIR).
- Current evidence for optimal antibiotic strategies in DAIR for early PJI is limited.
Purpose of the Study:
- To review the current understanding and evidence regarding antibiotic treatment for early PJI managed with DAIR.
- To identify uncertainties and areas needing further research in antibiotic regimens for early PJI.
Main Methods:
- Literature review focusing on studies related to early PJI management.
- Analysis of existing recommendations and guidelines, including Zimmerli's algorithm.
- Evaluation of evidence supporting specific antibiotic choices (e.g., rifampin, fluoroquinolones) and treatment parameters.
Main Results:
- DAIR is a viable option for many early PJI cases meeting specific criteria.
- Rifampin-containing regimens are suggested for gram-positive infections, and fluoroquinolones for gram-negative.
- Significant uncertainties remain regarding optimal antibiotic duration, dosage, route, and combination therapy.
Conclusions:
- While DAIR is a recognized approach for early PJI, the optimal antibiotic treatment remains unclear.
- Further high-quality research is essential to establish evidence-based guidelines for antibiotic therapy in early PJI.
- Current recommendations rely heavily on limited data, expert opinion, and experimental findings.
Abstract:
Periprosthetic joint infection (PJI) is a devastating complication that can occur following any arthroplasty procedure. Approximately half of these infections develop within the first year after arthroplasty, mainly in the first 1 to 3 months. These infections are known as early PJI. It is widely accepted that many early PJIs can be successfully managed by debridement, irrigation, and prosthetic retention, followed by a course of biofilm-effective antibiotics (debridement, antibiotics, implant retention procedure), but candidate patients should meet the requirements set down in Zimmerli's algorithm. The best antibiotic regimen for acute PJI treated without implant removal remains uncertain. Rifampin-containing regimens, when feasible, are recommended in gram-positive infections, and fluoroquinolones in gram-negative cases. The duration, dosage, and administration route of antibiotics and the use of combined therapy are matters that requires further clarification, as the current level of evidence is low and most recommendations are based on experimental data, studies in small series, and expert experience.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Urinary Tract Calculi VI: Surgical Management
Tonsillitis II: Management
Pericarditis III: Medical Management
Acute Pyelonephritis I: Introduction

